322 related articles for article (PubMed ID: 30340754)
1. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation.
Crockett SD; Greer KB; Heidelbaugh JJ; Falck-Ytter Y; Hanson BJ; Sultan S;
Gastroenterology; 2019 Jan; 156(1):218-226. PubMed ID: 30340754
[No Abstract] [Full Text] [Related]
2. Opioid-Induced Constipation (OIC) Guideline.
Crockett S; Greer KB; Sultan S
Gastroenterology; 2019 Jan; 156(1):228. PubMed ID: 30389393
[No Abstract] [Full Text] [Related]
3. American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.
Hanson B; Siddique SM; Scarlett Y; Sultan S;
Gastroenterology; 2019 Jan; 156(1):229-253.e5. PubMed ID: 30337104
[No Abstract] [Full Text] [Related]
4. Opioid-lnduced Constipation (OIC) Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2019 Jan; 156(1):227. PubMed ID: 30389392
[No Abstract] [Full Text] [Related]
5. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
[No Abstract] [Full Text] [Related]
6. Pharmacological Treatment of Opioid-Induced Constipation Is Effective but Choice of Endpoints Affects the Therapeutic Gain.
Nusrat S; Syed T; Saleem R; Clifton S; Bielefeldt K
Dig Dis Sci; 2019 Jan; 64(1):39-49. PubMed ID: 30284134
[TBL] [Abstract][Full Text] [Related]
7. Naldemedine (Symproic) for opioid-induced constipation.
Med Lett Drugs Ther; 2017 Dec; 59(1535):196-198. PubMed ID: 29186083
[No Abstract] [Full Text] [Related]
8. Naldemedine effective in treating opioid-induced constipation.
Brower V
Lancet Oncol; 2017 Jun; 18(6):e306. PubMed ID: 28483411
[No Abstract] [Full Text] [Related]
9. Opioid-induced constipation.
Wein S
J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):382-4. PubMed ID: 23216186
[TBL] [Abstract][Full Text] [Related]
10. Targeted Novel Pharmacotherapy to Improve Outcomes in Opioid-Induced Constipation.
Gupta A
J Fam Pract; 2015 Nov; 64(11 Suppl 2):. PubMed ID: 26697546
[No Abstract] [Full Text] [Related]
11. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
12. Naloxegol oxalate, pirfenidone, and nintedanib.
Hussar DA; Jeon MM
J Am Pharm Assoc (2003); 2015; 55(4):461-3. PubMed ID: 26161491
[No Abstract] [Full Text] [Related]
13. Current concepts in the management of opioid-induced constipation.
Walters JB; Montagnini M
J Opioid Manag; 2010; 6(6):435-44. PubMed ID: 21269005
[TBL] [Abstract][Full Text] [Related]
14. Methylnaltrexone for opioid-induced constipation in advanced illness.
Sanz Rubiales A; del Valle Rivero ML
N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955
[No Abstract] [Full Text] [Related]
15. Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?
Pannemans J; Corsetti M
Curr Opin Pharmacol; 2018 Dec; 43():53-58. PubMed ID: 30189347
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological therapies for opioid induced constipation in adults with cancer.
Boland JW; Boland EG
BMJ; 2017 Aug; 358():j3313. PubMed ID: 28768637
[No Abstract] [Full Text] [Related]
17. Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
Esmadi M; Ahmad D; Hewlett A
J Gastrointestin Liver Dis; 2019 Mar; 28(1):41-46. PubMed ID: 30851171
[TBL] [Abstract][Full Text] [Related]
18. Overview and treatment of opioid-induced constipation.
McCarberg BH
Postgrad Med; 2013 Jul; 125(4):7-17. PubMed ID: 23782897
[No Abstract] [Full Text] [Related]
19. Opioid side effects--mechanism-based therapy.
Berde C; Nurko S
N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126
[No Abstract] [Full Text] [Related]
20. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
White WB; Kowey P; Diva U; Sostek M; Tummala R
J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
